Our technology
Purity Information Exchange (PIE)
AI-driven clinical trial acceleration
The Purity Information Exchange (PIE) is a next-generation, AI-powered platform purpose-built to transform the speed, efficiency, and accuracy of clinical research. Developed specifically for Sponsors, CROs, and trial sites, PIE integrates patient recruitment, data aggregation, and real-time monitoring into a single, secure, and compliant ecosystem.
Key capabilities
PIE bundles seven core capabilities into a single platform—designed around the operational realities of running clinical trials at scale.
Patient Identification
- Uses advanced AI to identify eligible patients across our national network of clinical trial sites.
- Matches study-specific inclusion/exclusion criteria—even for complex, multi-factor protocols—within seconds.
- Significantly reduces recruitment time compared to industry norms.
Data Integration
- Integrates with many Electronic Medical Records, including most of the top ambulatory systems.
- Aggregates data across EMR, CTMS, ePRO, and EDC platforms for unified reporting and analytics.
Operational Efficiency
- Automates recruitment workflows, pre-screening, and eligibility verification.
- Reduces administrative burden and manual data handling, delivering significant savings for Sponsors.
Regulatory Compliance
- Fully compliant with HIPAA, GDPR, and FDA 21 CFR Part 11 standards.
- Integrated audit trails, secure user authentication, and role-based access controls.
Data Security
- Enterprise-grade encryption for all data in transit and at rest.
- Continuous system monitoring with intrusion detection and prevention protocols.
Predictive & Adaptive AI
- Predicts enrollment timelines and identifies at-risk sites for early intervention.
- Adapts recruitment strategies in real time to ensure study milestones are met or exceeded.
Scalability
- Built to manage single-site trials or global, multi-country studies with equal efficiency.
The Purity Health strategic advantage
Compared to the manual recruitment and data aggregation processes used by most CROs, PIE delivers measurable acceleration in trial start-up and patient enrollment. By uniting AI-driven patient identification with deep system interoperability, PIE helps Sponsors bring promising therapeutics to market faster—reducing both time-to-market risk and capital burn.